<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="480999">Vinorelbine</z:chebi> (NVB) is a novel <z:chebi fb="0" ids="27288">vinca alkaloid</z:chebi> FDA approved for use in some advanced <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its role in non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) is still not well defined </plain></SENT>
<SENT sid="2" pm="."><plain>NVB is an antimicrotubule agent, but as yet, it is not known whether it induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>By flow cytometry using nuclear staining (<z:chebi fb="0" ids="51240">propidium iodide</z:chebi>) and annexin V, we demonstrated that NVB and <z:chebi fb="0" ids="28445">vincristine</z:chebi> (VCR) induced both mitotic arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, in a drug exposure time dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Cell cycle kinetics in 3 different cell lines varied during <z:chebi fb="0" ids="27288">vinca alkaloid</z:chebi> treatment </plain></SENT>
<SENT sid="5" pm="."><plain>The annexin V method showed that <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, as opposed to <z:mp ids='MP_0001651'>necrosis</z:mp>, was the dominant mode of cell kill of chemosensitive <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Phosphatidylserine expression on the cell surface was detectable as a hallmark of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> at earlier drug exposure when compared to conventional flow cytometry with PI staining </plain></SENT>
<SENT sid="7" pm="."><plain>By Western blot analysis, we demonstrated that CPP32 or caspase-3, a critical <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inducer, and its active subunits p20 and p11 were upregulated in chemo- and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-sensitive <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells treated with NVB </plain></SENT>
<SENT sid="8" pm="."><plain>Our data contributes to the emerging hypothesis suggesting that widely divergent exogenous stimuli and chemotherapeutic agents can effect <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells via different pathways involving the caspases </plain></SENT>
<SENT sid="9" pm="."><plain>We believe that <z:chebi fb="0" ids="480999">vinorelbine</z:chebi> may be a potentially important drug in the treatment of NHL in the future </plain></SENT>
</text></document>